A recent case-control study conducted within the Bushehr Elderly Health (BEH) cohort in southern Iran has identified a significant association between the ESR1 rs2234693 (PvuII) polymorphism and trabecular bone microarchitecture. While the research did not find a correlation between this genetic variant and osteoporosis defined by bone mineral density (BMD), it revealed a distinct relationship with the Trabecular Bone Score (TBS), a metric used to evaluate skeletal microstructural integrity.
Osteoporosis is a complex, multifactorial skeletal disorder influenced by both genetic and environmental factors. The estrogen receptor alpha, encoded by the ESR1 gene, is known to serve as a key regulator of bone remodeling. Because of its functional role in skeletal homeostasis, the PvuII polymorphism (rs2234693 T > C) has been the subject of ongoing scientific investigation, though previous findings regarding its association with osteoporosis have remained controversial in the literature.
To further investigate this relationship, researchers analyzed data from 475 participants aged 50 years and older from the Bushehr Elderly Cohort. The study group consisted of 138 osteoporotic individuals and 337 non-osteoporotic individuals. The primary objective was to determine whether specific genotype distributions of the ESR1 rs2234693 variant were statistically more frequent in one group compared to the other.
The study found that genotype distributions did not differ significantly between osteoporotic and non-osteoporotic participants when using BMD as the primary diagnostic criterion. Consequently, no significant association was observed between the ESR1 rs2234693 polymorphism and BMD-defined osteoporosis within this cohort.
However, the researchers observed a significant difference when evaluating Trabecular Bone Score. Individuals carrying the TT genotype demonstrated a higher prevalence of normal TBS at 61.8 percent, compared to carriers of the TC (47.3 percent) and CC (47.2 percent) genotypes. This suggests that the TT genotype may offer a relative protective effect regarding the preservation of trabecular bone structure in this population.
Conversely, the C allele was significantly more frequent among individuals categorized with reduced TBS. The frequency of the C allele in the reduced TBS group was 52.7 percent for TC carriers and 52.85 percent for CC carriers, compared to 38.2 percent for those with the TT genotype. These statistical differences remained evident after the researchers adjusted for potential confounding variables, including age, body mass index (BMI), sex, and serum vitamin D levels.
These findings suggest that the effects of the ESR1 rs2234693 polymorphism may be more pronounced on trabecular bone microarchitecture than on standard BMD measurements. The results support the use of TBS as a complementary tool for evaluating the skeletal effects of ESR1 genetic variations. The authors of the study note that while these results provide evidence of a specific genetic link to bone texture, further large-scale research is necessary to confirm these observations across broader populations.
Subject of Research: Genetic association between ESR1 PvuII polymorphism and trabecular bone score in elderly adults.
Article Title: Association between genetic variant in estrogen receptor alpha gene and bone texture in bushehr elderly health (BEH) cohort
Article References: Kalashami, Z. N., Fahimfar, N., Rezazadeh, A., Razi, F., Panahi, N., Taheri, F., & Amoli, M. M. (2026). Association between genetic variant in estrogen receptor alpha gene and bone texture in bushehr elderly health (BEH) cohort. Molecular Biology Reports, 53(1), Article 1982. https://doi.org/10.1007/s11033-026-13184-w
Image Credits: AI Generated
DOI: 10.1007/s11033-026-13184-w
Keywords: ESR1, rs2234693, PvuII polymorphism, osteoporosis, Trabecular Bone Score, TBS, bone microarchitecture, bone mineral density, BMD, Bushehr Elderly Health cohort, BEH cohort, genetics, skeletal health, elderly health, estrogen receptor alpha
News Source: Drew Townsend. (November 18, 2026). Estrogen Receptor Gene Variant Associated With Reduced Trabecular Bone Score. Scienmag.



